G6PC1 and Hypoglycemia: Since this enzyme has a crucial role in hepatic glucose output, we can suggest that atorvastatin and diacerein, by reducing the downstream TLR4 signaling, can contribute to restoring G6Pase tissue levels and in this regard hepatic glucose production, thus preventing hypoglycemia and improving disease tolerance.